NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
Ontology highlight
ABSTRACT: Several studies have revealed a correlation between chronic inflammation and nicotinamide adenine dinucleotide (NAD+) metabolism, but the precise mechanism involved is unknown. Here, we report that the genetic and pharmacological inhibition of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in the salvage pathway of NAD+ biosynthesis, reduced oxidative stress, inflammation, and keratinocyte DNA damage, hyperproliferation, and cell death in zebrafish models of chronic skin inflammation, while all these effects were reversed by NAD+ supplementation. Similarly, genetic and pharmacological inhibition of poly(ADP-ribose) (PAR) polymerase 1 (Parp1), overexpression of PAR glycohydrolase, inhibition of apoptosis-inducing factor 1, inhibition of NADPH oxidases, and reactive
SUBMITTER: Martinez-Morcillo FJ
PROVIDER: S-EPMC8601609 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA